Most of the results of the mid-term election are now in and can be reviewed on-line. Jeff Mervis at SCIENCE has a nice summer of what the changes in the House mean, here. My own sense is that with Eddie Bernice Johnson (D-TX) as the likely chair for House Science, the tenor of that Committee’s relationship with the non-biomedical US Science R&D agencies is going to improve significantly. Specifically with regards to Climate Change, and more generally with regards to a less adversarial oversight role. I think that’s probably a good thing.
NASA and probably also NSF lost a key advocate in John Culberson (R-TX) as chair of CJS, the appropriations committee responsible for the two agencies. On the other hand, NASA will probably be able to finesse the timing of when they send a probe to Europa and NSF’s contacts with Chinese science may be a bit less fettered (although the one from the White House is still pretty hawkish).
Barbara Comstock’s loss in Virginia is complex. While she could be a thorn in the side of NSF (e.g. NEON), she was extremely supportive of the DC metro area federal workforce and this benefited science agencies who depend on expert staff to keep the wheels moving.
My sense is that NIH is still coming out of this smelling like a rose. A more conservative senate may put the brakes on some hot-button research topics, but in general, I am pretty optimistic about the biomedical sector.